Attrogy

diflunisal · Purpose Pharma International AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Attrogy, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: EMA Authorised: Attrogy (diflunisal) — Purpose Pharma International AB